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Abstract
Esophageal stents are widely used to treat a variety of problems, most commonly malignant dysphagia. Malignant dys-
phagia can be present in patients with unresectable, resectable, and potentially resectable cancer. Esophageal stents are also
utilized to treat esophageal strictures, ﬁstulas, perforations, and leaks. Stent placement usually requires both endoscopic
and ﬂuoroscopic guidances, but can be done with either modality safely. Most stents are placed distally and across the
gastroesophageal junction, but proximal stent placement (which requires more precise placement) can also be performed.
Complications include bleeding and perforation (which are rare) as well as migration, tumor overgrowth, and tumor
ingrowth (which are more common). The techniques of placement of an esophageal stent with some tips and tricks
regarding placement and management of complications are reviewed in the given video. This article is part of an expert
video encyclopedia.
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Video Related to this Article
Materials
• Upper endoscope.
• Guide wires.
• Straight biliary catheters.
• Fluoroscopy.
• Esophageal stents.
Background and Endoscopic Procedures
In general, adequate stent deployment involves placing the
stent across the site of the obstruction (generally a tumor in
patients with malignant dysphagia) with at least 1 cm of the
stent positioned above below the stricture; some very proximal
stents require a more precise placement of the proximal end of
the stent, as shown in the video.
Some physicians like to mark the proximal and distal ends
of the tumor with contrast injections or endoscopic clips, or
use external ﬂuoroscopic markers, such as coins, paper clips,
or other metallic objects. These can all be helpful during stent
placement as they clearly delineate the proximal and distal
ends of the tumor. The use of these proximal and distal
markers should be considered optional, and many physicians
prefer to use contrast injection alone to delineate the stricture
more clearly, or ﬂuoroscopic markers, such as the position of
the endoscope when it is located at the proximal and distal
ends of the tumor when deciding on stent length and to guide
stent placement.
• Most stents are placed for malignant dysphagia, but benign
indications exist.
Key Learning Points/Tips and Tricks
In general, dilation of a stricture before placing the stent is not
required. Dilation of the stricture, especially a malignant
stricture, is more likely to increase the risk of perforation than
it is to assist with stent deployment in any meaningful way. A
variety of guide wires can be used for esophageal stent place-
ment. There is no standard guide wire. Some physicians like a
soft and ﬂoppy guide wire that can easily traverse strictures.
Other physicians like a very stiff wire (such as a Savary wire).
Guide wire choice is best individualized to the patient’s overall
situation.
Once the stricture in question has been adequately
delineated and guide wire access through the entire length
of the stricture has been obtained, the stent is advanced
across the stricture and deployed. Stents can be deployed
under ﬂuoroscopic guidance, endoscopic guidance, or a
combination of the two. Stent deployment can be performed
with the physician directly operating the deployment catheter
to control the stepwise release of the prosthesis, or the actual
deployment can be controlled by an assistant/technician while
the physician holds the delivery catheter itself and makes
ﬁne adjustments to the stent position during deployment.
Both of these techniques tend to result in excellent stent
placement. Some currently available stents can be recon-
strained once stent deployment has begun; this allows sub-
optimal positions or deployments to be abandoned via
reconstraining the stent.
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
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It is important to remember that complete stent deploy-
ment may not occur immediately. It often takes 48–72 h for
complete stent deployment to take place. Some currently
available stents may leave the lumen very narrow following
deployment, yet will provide excellent relief from dysphagia
after the stent fully expands. Once the stent is in place, it is
generally not necessary to do a thorough endoscopic evalu-
ation of the entire stent. If this is performed, it may increase
the risk of stent migration. Nonetheless, in some patients, a
full evaluation of the stent following appointment is required
and, if performed gently, is usually safe.
• Stent placement should be precise.
• Stent position can be adjusted during deployment.
• Use of guide wires and ﬂuoroscopy is extremely helpful
during deployment.
• Stent expansion may take time to fully develop after
deployment.
Complications and Risk Factors
Immediate complications of stent placement include pain,
bleeding, and perforation. Pain can be absent to severe, and
tends to abate over a period of one week. If pain is protracted
and/or severe, the stent can be endoscopically removed in
most cases. Bleeding is often mild and subclinical. Perforation
is also uncommon. Gastroesophageal reﬂux disease (GERD)
may develop if the stent is placed across the gastroesophageal
junction. Delayed complications are much more common.
Delayed complications include stent migration (which is
much more common in the era of fully covered stents) as well
as tumor ingrowth, tumor overgrowth, delayed bleeding, and
delayed perforation. In general, migration, tumor ingrowth,
and tumor overgrowth are the most commonly seen delayed
complications. There is ongoing debate about whether
chemotherapy and/or radiation therapy increases the risk of
complications in patients receiving esophageal stents. Older
literature supports the notion that chemotherapy and/or ra-
diation therapy increases the risk of complications; newer
literature tends not to see this association.
In the current era of fully covered esophageal stents, many
patients receive stents before neoadjuvant therapy. Stents placed
in this context have a very high rate of migration, approaching
50%. Migration in this context may not necessarily be viewed as
a complication as it may reﬂect tumor response to neoadjuvant
therapy. Patients who migrate an esophageal stent into their
stomach following neoadjuvant therapy can have the stent re-
moved endoscopically. Alternatively, patients who undergo eso-
phagectomy can have the stent removed, either from the
esophagus or the stomach, by the surgeon at the time of surgery.
• Complications include bleeding, pain, migration, GERD,
tumor overgrowth, tumor ingrowth, and perforation.
Alternatives
Alternatives to esophageal stents include nasal enteric tubes,
gastrostomy tubes, and jejunostomy tubes. Total parenteral
nutrition can also be used in patients who are not candidates
for stent placement.
Scripted Voiceover
Time (min:sec) Voiceover text
00:01-:16 Esophageal stents are commonly utilized for a
variety of purposes and in modern clinical
practice.
00:20-:28 The most common indications for the treatment
of malignant dysphasia, stents can be placed in
preoperative and non-operative candidates.
00:31-:36 Other indications include the treatment of benign
esophageal strictures, ﬁstulas, and leaks.
00:41-:45 The representative stent deployment will now be
shown focusing on the endoscopic view.
00:46-:58 The patient in this case has a very proximal
esophageal cancer. There is complete
obstruction of the esophagus and the
endoscope cannot pass into the distal
esophagus or the stomach.
00:59–1:09 The guidewire in this case, a straight biliary
guidewire through a straight biliary catheter is
advanced through the tumor and access is
obtained to the distal esophagus and stomach.
1:10–1:23 The stent is then advanced over the wire and
deployed. Because the tumor is very proximal
in this patient, an effort is made to overlap the
proximal end of the stent to the very proximal
end of the tumor as much as possible.
1:28–1:34 After stent deployment the delivery catheter and
associated guidewire can be removed from the
patient.
1:38–1:44 The stent can then be inspected for position,
patency, and signs of any immediate
complications.
1:48–1:56 You can see the stent is in excellent position;
tumor is visible through the stent entrance. The
stent is widely patent.
2:02–2:45 Representative stent deployment will now be
shown emphasizing the ﬂuoroscopic view. In
this patient the endoscope could be advanced
through the tumor to the distal portion of the
mass into the gastric cardia. This position is
marked endoscopically with an image. The
endoscope is then withdrawn to the proximal
aspect of the tumor and an image is also
obtained. Thus, the distal and the proximal
end of the stricture are then clearly marked.
A wire, in this case a savory wire, is advanced
through the tumor and into the stomach and
the endoscope is removed over the wire.
The stent, in this case a fully covered stent,
is advanced across the stricture, the distal most
portion of the stent, below the bottom of the
tumor.
2:48–2:58 Final adjustments are made, deployment is
allowed to commence. In this patient, the stent
is deployed in a distal proximal manner as is
most commonly performed.
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3:03–3:15 The stent is fully deployed, clearly bridging the
entire tumor. The delivery catheter and its
guidewire are then removed from the patient
and the stent is left in place bridging the entire
tumor.
3:20–3:25 Endoscopic inspection following deployment
usually reveals a fully deployed and well placed
stent.
3:29–3:44 Here you see a fully covered stent in good
position across a tumor; tumor is visible
through the stent. Through and through
endoscopic evaluation of the stent is not
required post deployment, but can be
performed if desired. Here you see a retroﬂex
view of a distal stent.
3:46–4:05 Endoscope is then straightened and removed
through the stent. Distal portion of the stent is
in good position in the gastric cardia. The stent
is patent without signs of complication or other
difﬁculties, and the proximal end of the stent is
above the proximal end of the tumor.
4:13–4:31 If clinically indicated, a stent can be placed in the
very proximal esophagus. This requires very
precise placement by the endoscopist. Here
you see a fully covered stent placed
immediately below the upper esophageal
sphincter, and a patient with a very proximal
cancer. This patient tolerated the stent well.
4:35–4:44 Complications can occur. In this case, you see an
infolded stent immediately after deployment.
4:48–5:23 Infolding can occur due to poor placement,
incorrect stent size, or may be a sign of a
noncompliant tumor. The stent can be left in
place, removed or manually adjusted to allow
complete expansion. Stent placement can be
adjusted following deployment as needed. A rat
tooth forceps allows for rapid and efﬁcient stent
adjustment in most cases. This video shows
the use of a rat tooth forceps to proximally
adjust the position to fully cover an esophageal
stent. The stent is moved approximately for a
distance of 2 cm.
5:25–5:38 When the stent is felt to be in adequate position,
the rat tooth forceps release the stent and the
position can be directly assessed
endoscopically. If satisfactory, no other
adjustment is required.
5:48–6:05 Some stent migrations are associated with
recurrent dysphagia and warrant stent
replacement. At other times stent migration is a
sign of response to neoadjuvant therapy. Stent
migration is unfortunately a common
development following deployment, especially
with fully covered stents. Most migrations can
be managed endoscopically.
6:09–7:08 This video illustrates complete migration of an
esophageal stent into the gastric cardia. The
stent is grasped by rat tooth forceps around the
proximal retrieval string if possible. The stent is
then withdrawn through the tumor and the
esophagus with the rat tooth forceps. Note here
that when the endoscope is removed from the
patient, the stent has come off the rat tooth
forceps. The rat tooth forceps have been
withdrawn back into the endoscope and the
patient is reintubated. The stent is located just
below the level of upper esophageal sphincter.
The endoscope passes into the proximal
esophagus. The stent is grasped, again with the
rat tooth forceps, by the retrieval string and
removed from the patient. Other complications
including tumor ingrowth and overgrowth can
be treated by stent within stent placement.
Perforations are rare, but can often be managed
by other stent placements.
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